Praxis Precision Medicines Inc
PRAXBuild a strategy around PRAX
Praxis Precision Medicines Inc AI Insights
Informational only. Not investment advice.Snapshot
- P/S ratio of 792x vs industry median 2.7x - valuation prices in blockbuster drug success with zero margin for error[P/S Ratio]
- Cash burn of 229M TTM against 150M cash leaves ~8 months runway without new financing[Free Cash Flow TTM]
- R&D of 246M is 33x revenue (7.5M TTM) - pure clinical-stage bet with no commercial validation[Research and Development TTM]
Watch Triggers
- Cash and Equivalents: Falls below 100M — Triggers emergency financing at unfavorable terms or forced partnership
- Issuance of Capital Stock: Exceeds 50M in single quarter — Signals aggressive dilution; watch for >10% share count increase
- Research and Development TTM: Drops >20% sequentially — May indicate pipeline prioritization or cash preservation mode
Bull Case
Near-zero debt (0.001 D/E) and 344M equity provides clean balance sheet for partnership deals or acquisition premium
5.9B market cap on 7.5M revenue implies market sees high probability of clinical success in CNS pipeline
Bear Case
8-month cash runway at current burn forces near-term dilution or distressed deal regardless of pipeline progress
792x P/S assumes near-perfect execution - any clinical setback creates 80%+ downside to industry median valuation
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage PRAX's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Equity dilution or partnership deal likely within 12 months given cash runway constraints
- 150M cash vs 229M annual burn rate
- 6M raised recently signals ongoing capital needs
- Zero debt capacity with minimal assets
Valuation Context
Caveats
PRAX Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$9.77B | — | ||
$9.24B | — | ||
0.00 | — | ||
$0 | — | ||
$-13.39 | — | ||
0% | — | ||
0% | — | ||
$-282.33M | — | ||
-35.3% | +28.2% | — | |
Beta 5Y (Monthly) | unknown | — |
PRAX Dividend History
PRAX Stock Splits
PRAX SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
05/07/26 | 03/31/26 | 10-Q | |
02/19/26 | 12/31/25 | Unknown | |
11/05/25 | 09/30/25 | 10-Q | |
08/04/25 | 06/30/25 | 10-Q | |
05/02/25 | 03/31/25 | 10-Q | |
02/28/25 | 12/31/24 | 10-K | |
11/06/24 | 09/30/24 | 10-Q | |
08/13/24 | 06/30/24 | 10-Q | |
05/13/24 | 03/31/24 | 10-Q | |
03/05/24 | 12/31/23 | 10-K | |
11/07/23 | 09/30/23 | 10-Q | |
08/09/23 | 06/30/23 | 10-Q | |
05/11/23 | 03/31/23 | 10-Q | |
02/07/23 | 12/31/22 | 10-K | |
11/09/22 | 09/30/22 | 10-Q | |
08/08/22 | 06/30/22 | 10-Q | |
05/09/22 | 03/31/22 | 10-Q | |
02/28/22 | 12/31/21 | 10-K | |
11/03/21 | 09/30/21 | 10-Q | |
08/16/21 | 06/30/21 | 10-Q | |
05/11/21 | 03/31/21 | 10-Q | |
03/17/21 | 12/31/20 | 10-K | |
11/23/20 | 09/30/20 | 10-Q | |
10/16/20 | 06/30/20 | 424B4 | |
05/11/21 | 03/31/20 | 10-Q | |
10/16/20 | 12/31/19 | 424B4 | |
11/23/20 | 09/30/19 | 10-Q |